Patient Resources

Talking to your doctor about peptide therapy

How to bring peptide therapy up with your primary-care physician, what to say, what to expect, and when it makes sense to keep them in the loop.

3 min readUpdated May 12, 2026Educational, not medical advice

Why this matters

Most adults pursuing peptide therapy do it through a specialty telehealth service like Crystal Clear, because peptide protocols are not part of standard primary-care training. That does not mean your primary care doctor is out of the picture. Coordination across your care team is the responsible move, especially if you are on other medications or have ongoing conditions.

When to bring it up

Three situations where you should definitely tell your primary care doctor:

  1. You take other prescription medications. Some interactions matter. Your primary care physician has the full picture of what else you are on.
  2. You have ongoing conditions like diabetes, thyroid issues, or cardiovascular disease. Even if a peptide protocol does not directly interact with the management, your primary doctor should know.
  3. You are due for routine bloodwork. Some peptide protocols make sense to monitor with labs. Coordinating with your primary care doctor for the workup is easier than ordering it separately.

If you are an otherwise-healthy adult not on other medications, telling your primary care doctor is still a good idea but less urgent.

How to frame the conversation

Most primary-care doctors are not trained on peptides. Some are dismissive; some are curious. Your job is to be informed, not defensive.

A useful opener: "I started a peptide protocol through a telehealth specialty service. I want to make sure you know what I am taking. Can we talk through whether anything matters for the rest of my care?"

Most physicians will ask:

  • What is the peptide and what dose?
  • Who is prescribing it?
  • What is the protocol length?

Have those answers ready. The Crystal Clear medication packaging includes all of it.

What if your doctor pushes back

Some doctors will tell you they would not have prescribed it. That is reasonable. Primary care is not where peptide protocols live. The question is whether they have a specific clinical concern.

If they raise something concrete, an interaction, an existing condition that complicates the therapy, a lab they want to run first, take it seriously. Email your Crystal Clear clinician and share what your primary doctor said. The two can communicate if needed.

If the pushback is "I do not believe in peptides," that is a values disagreement, not a clinical one. You can keep your protocol and keep your primary care relationship.

What you do not need to do

You do not need your primary care doctor's permission to pursue peptide therapy. The Crystal Clear clinician is licensed and authorized to write the prescription. Coordinating is good practice. Asking permission is not the model.

Disclaimer

General educational reference. Not medical advice.

The information on this page is published for general educational purposes. It is not a substitute for medical advice, diagnosis, or treatment. Always follow the specific instructions provided by your prescribing clinician, and consult them before changing how you take any compounded medication.

Crystal Clear RX Wellness is not a pharmacy. Compounded medications are prepared by a licensed 503A compounding pharmacy partner pursuant to a valid prescription written by a licensed clinician for an individually identified patient. A licensed prescriber must evaluate your eligibility before any compounded medication is dispensed. The therapies referenced on this page are not FDA-approved drugs; they are compounded formulations prepared at the discretion of the prescribing clinician under section 503A of the Food, Drug, and Cosmetic Act.

References to USP guidance, beyond-use dating, or technique norms reflect generally accepted practice for at-home subcutaneous self-administration. They do not override prescriber-specific instructions, product labeling, or the policies of your dispensing pharmacy.

For full regulatory information, see the 503A disclosure.